Pmv Pharmaceuticals
PMVP

Pmv Pharmaceuticals (PMVP) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$5.00Sep 4, 2026
Ladenburg ThalmannInitiated CoverageBuy$3.00Jul 8, 2026
OppenheimerMaintainedOutperform$5.00 from $6.00May 13, 2026
HC Wainwright & Co.MaintainedBuy$5.00Mar 20, 2025
HC Wainwright & Co.MaintainedBuy$5.00Aug 20, 2024
HC Wainwright & Co.MaintainedBuy$5.00May 30, 2024
HC Wainwright & Co.MaintainedBuy$5.00May 14, 2024
Craig-HallumInitiated CoverageBuy$6.00May 13, 2024
JefferiesInitiated CoverageBuy$5.00Apr 12, 2024
HC Wainwright & Co.MaintainedBuy$5.00Mar 7, 2024
Ladenburg ThalmannInitiated CoverageBuy$7.00Dec 27, 2023
HC Wainwright & Co.MaintainedBuy$5.00 from $29.00Oct 16, 2023
HC Wainwright & Co.MaintainedBuy$29.00 from $35.00Aug 11, 2023
HC Wainwright & Co.MaintainedBuy$35.00May 17, 2023
OppenheimerMaintainedOutperform$15.00May 11, 2023

Frequently asked questions

  • What is the latest analyst rating on PMVP?

    On Sep 4, 2026, HC Wainwright & Co. maintained Pmv Pharmaceuticals at Buy with a price target of $5.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.